《大行報告》瑞銀:即使美國下調對華關稅 不代表貿易關係轉向
白宮表示美國總統拜登的團隊仍在考慮是否降低對中國進口商品的關稅以緩解通脹壓力。瑞銀投資銀行亞洲經濟研究團隊表示,美國對華關稅複審的結果仍不確定,部分投資者預計7月初美國將大規模取消對華商品加徵的關稅。
瑞銀投資銀行亞洲經濟研究主管暨首席中國經濟學家汪濤認為,即便此前加徵關稅得以下調,也不代表著中美貿易關係轉向,美國仍可能出台其它限制性措施,如下調消費品關稅的同時也可能推出針對工業品的貿易政策,美國可能發起另一項針對產業政策的301調查。
她指出,即便關稅調整實施,中國企業也可能面臨更多限制,例如技術准入限制等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.